ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,839.81
0.88%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Orphazyme AS (ORPH)

  7. Orphazyme AS (ORPH) News

Orphazyme AS (ORPH)

Orphazyme AS
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORPH
DateTimeSourceHeadlineSymbolCompany
10/02/202312:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORPHOrphazyme AS
09/06/202211:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
23/05/202221:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
16/05/202221:31Edgar (US Regulatory)Amended Notification That Form 20-f Will Be Submitted Late (nt 20-f/a)NASDAQ:ORPHOrphazyme AS
16/05/202221:27Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
16/05/202213:39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
29/04/202212:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
29/04/202212:40Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
07/04/202211:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
06/04/202211:40Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
04/04/202222:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
01/04/202211:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
31/03/202222:42Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ORPHOrphazyme AS
31/03/202220:17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
29/03/202212:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
24/03/202210:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ORPHOrphazyme AS
22/03/202212:02Dow Jones NewsOrphazyme Begins Delisting ADSs From NasdaqNASDAQ:ORPHOrphazyme AS
22/03/202210:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
21/03/202220:24Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:ORPHOrphazyme AS
18/03/202212:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
10/03/202222:12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
03/03/202212:44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
24/02/202211:27Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
18/02/202221:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
14/02/202221:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
11/02/202212:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
03/02/202221:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORPHOrphazyme AS
31/01/202217:45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
25/01/202211:25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
19/01/202211:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ORPHOrphazyme AS
 Showing the most relevant articles for your search:NASDAQ:ORPH

Your Recent History

GATE
BCDNETH
BlockCDN
NASDAQ
LGAC
Lazard Growth Acquisitio...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved